Crinetics Pharmaceuticals (CRNX) Earnings
|
Expand Research on CRNX
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -7.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | -$1.28 | N/A | N/A | $8.52M | N/A | N/A | N/A | ||
| 2/26/26 | Q425 | -$1.29 | -$1.34 | +$0.05 | $6.1M | $4M | N/A |  | | Details | |
| 11/6/25 | Q325 | -$1.38 | -$1.25 | -$0.13 | $143K | $491K | N/A | | | Details | |
| 8/7/25 | Q225 | -$1.23 | -$1.10 | -$0.13 | $1M | $750.11K | N/A | | | Details | |
| 5/8/25 | Q125 | -$1.04 | -$0.93 | -$0.11 | $360K | $137.5K | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.88 | -$0.88 | $0.00 | N/A | $666.67K | N/A | | | Details | |
| 11/12/24 |
Q324 | N/A | -$0.91 | N/A | N/A | $218.09K | N/A | N/A | N/A | ||
| 8/8/24 | Q224 | -$0.94 | -$0.86 | -$0.08 | $390K | $467.27K | N/A | | | Details |
